HIGHLIGHTS
- who: Guerrieri et_al BMC Pharmacology and colleagues from the (UNIVERSITY) have published the research work: Biological, pharmacological and immunological activities of novel 6-amino-acid-substituted 14-alkoxy- N -methylmorphinans, in the Journal: (JOURNAL)
- what: Novel MOP agonists acting in the periphery with combined immunosuppressive and analgesic properties may provide a new approach for the treatment of IBD.
SUMMARY
Of the three opioid receptors, μ (MOP), δ (DOP) and_(KOP), the MOP type is the most involved in the action of opioids in the gut. Experimental studies on models of intestinal inflammation and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.